Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11975059 IL-15-based fusions to IL-12 and IL-18

Patent 11975059 was granted and assigned to Altor BioScience on May, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Altor BioScience
Altor BioScience
0
Date Filed
December 1, 2023
0
Date of Patent
May 7, 2024
0
Patent Applicant
Altor BioScience
Altor BioScience
0
Patent Application Number
18526598
0
Patent Citations
‌
US Patent 9328159 Multimeric IL-15 soluble fusion molecules and methods of using same
0
‌
US Patent 9428573 Multimeric IL-15 soluble fusion molecules and methods of making and using same
0
‌
US Patent 9464127 Fusion molecules and IL-15 variants
0
‌
US Patent 9925247 IL-15-based molecules and methods of use thereof
0
‌
US Patent 10150805 Multimeric IL-15 soluble fusion molecules and methods of making and using same
0
‌
US Patent 10450359 IL-15 variants and uses thereof
0
‌
US Patent 11129883 IL-15-based fusions to IL-12 and IL-18
0
‌
US Patent 11571470 IL-15-based fusions to IL-12 and IL-18
0
‌
US Patent 11168138 Anti-PDL1, IL-15 and TGF-beta receptor combination molecules
0
‌
US Patent 8163879 Fusion molecules and IL-15 variants
0
•••
Patent Inventor Names
Bai Liu
0
Hing C. Wong
0
Lijing You
0
Robert Newman
0
Peter Rhode
0
Lin Kong
0
Warren D. Marcus
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11975059
0
Patent Primary Examiner
‌
Prema M Mertz
0
CPC Code
‌
A61K 38/20
0
‌
A61K 39/00114
0

Find more entities like US Patent 11975059 IL-15-based fusions to IL-12 and IL-18

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo